Agenda

Vaccines and Immune Therapies for Chronic Diseases

Tuesday, March 16, 2027, 8:30 AM - Wednesday, March 17, 2027, 5:15 PM

8:30 AM - 9:00 AM
Check-In and Breakfast
9:00 AM - 10:00 AM
Welcome Remarks & Keynote Presentation

9:00 AM

Welcome Remarks
Megan Prescott, PhD, The New York Academy of Sciences  

9:15 AM

Keynote Presentation
Rino Rappuoli, MD, PhD, Biotecnopolo di Siena Foundation 

10:00 AM - 10:35 AM
Networking Break
10:35 AM - 12:35 PM
Session I: Neurodegenerative Diseases

10:35 AM

Opening the Era of Immunotherapy and Vaccines for Alzheimer’s Disease 
Howard Feldman, MD, University of California, San Diego 

11:05 AM

Preventing Dementia with Shingles Vaccination? Evidence from Quasi-Randomized Vaccine Rollouts
Pascal Geldsetzer, MD, PhD, MPH, Stanford University

11:35 AM

To Be Announced 

12:35 PM - 1:05 PM
Session II: Short Talks Selected from Submitted Abstracts
1:05 PM - 2:25 PM
Networking Lunch and Poster Session
2:25 PM - 3:55 PM
Session III: Cancer

2:25 PM

To Be Announced 

2:55 PM

mRNA-Based Individualized Neoantigen Therapy for Melanoma
Clemens Krepler, MD, Merck 

3:25 PM

Personalized Vaccines for Pancreatic Cancer
Vinod Balachandran, MD, Memorial Sloan Kettering Cancer Center 

3:55 PM - 4:25 PM
Networking Break
4:25 PM - 5:15 PM
Session IV: Panel - Real World Evidence - Innovation and Clinical Trial Design

4:25 PM

Panel Discussion

5:10 PM

Closing Remarks

8:30 AM - 9:00 AM
Check-In and Breakfast
9:00 AM - 9:15 AM
Welcome Remarks

9:00 AM

Welcome Remarks
Megan Prescott, PhD, The New York Academy of Sciences  

9:15 AM - 10:45 AM
Session V: Viral Diseases

9:15 AM

HPV Therapeutic Vaccines
David Weiner, PhD, University of Pennsylvania 

9:45 AM

To Be Announced 

10:15 AM

To Be Announced 

10:45 AM - 11:20 AM
Networking Break
11:20 AM - 12:50 PM
Session VI: Bacterial Diseases

11:20 AM

Lyme Disease Vaccine
James Groark, MD, Pfizer 

11:50 AM

Therapies to Treat Porphyromonas Gingivalis Related Diseases 
Paul Cockle, PhD, Denteric 

12:20 PM

M72 Vaccine for Tuberculosis 
Alexander Schmidt, MD, PhD, Gates Foundation

12:50 PM - 2:15 PM
Networking Lunch
2:15 PM - 3:35 PM
Session VII: Industry Updates

2:15 PM

To Be Announced 

2:35 PM

AZD6750, a CD8α-guided IL-2 molecule, Enhances Hepatitis B Virus-Specific CD8+ T-Cell Activation and Function
Philip Swanson, PhD, AstraZeneca 

2:55 PM

Developing a Bispecific Antibody for Bronchiectasis Patients Chronically Colonized with Pseudomonas aeruginosa
Stacey Cromer Berman, PhD, AstraZeneca 

3:35 PM - 4:10 PM
Networking Break
4:10 PM - 5:00 PM
VIII: Closing Keynote

4:10 PM

Keynote Presentation
Peter Marks, MD, Lily 

4:55 PM

Closing Remarks
Megan Prescott, PhD, The New York Academy of Sciences  

Submit Your Abstract

Deadline: January 15, 2027

Are you interested in being considered for a short talk or poster session? Researchers at all levels and across disciplines and sectors can advance their work in a welcoming environment designed to encourage dynamic dialogues and meaningful exchange - propelling their research, and the science, forward.

Submit Now